Stay updated with breaking news from Philippe Cassier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of...
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce two...
R&D Day to highlight the Company’s strategy on its leading clinical programs and emerging firs-in-class portfolio in immuno-oncology;Presentations by leading clinicians to feature the latest data on Tedopi® and BI 765063.NANTES, France--(BUSINESS WIRE)--Regulatory News:OSE Immunotherapeutics (ISIN: FR0012127173; Mné...
Press release content from Business Wire. The AP news staff was not involved in its creation.
Upcoming Panel Discussion, Hosted by Xtalks on Precision Oncology: An Era that Calls for a New Model for Conducting Clinical Trials? Share Article During this discussion, the featured speakers will examine lessons learnt from the clinical development of targeted therapies such as immunotherapeutic agents, and current methodological challenges for new drug development in the precision oncology era. They will provide insights into a novel approach to conduct clinical research in the precision oncology era. Clinical trials have evolved from drug- to target-oriented trials, and this shift has rai...